An observational study in Infection Due to Resistant Bacteria, Multi-antibiotic Resistance and Antibiotic Prescription, sponsored by Association Clinique Thérapeutique Infantile du val de Marne. Completed at 1 site in France. Open to participants aged Up to 17 Years. Per ClinicalTrials.gov, last updated 2026-03-19.
Sponsored by Association Clinique Thérapeutique Infantile du val de Marne · Observational
This study is observational, multicenter and prospective study for surveillance of the use of new antibiotics in pediatrics for treated pediatrics infections due to multi-resistant bacteria
The main of this study is to evaluate the relevance of prescribing "new antibiotics" according to the antibiogram of the isolated bacteria or in the absence of bacteriological documentation
As this is a surveillance study, the clinical and biological characteristics of the children included will be described.
Association Clinique Thérapeutique Infantile du val de Marne is the lead sponsor of 15 studies on the registry; 11 are open to participants now.
Counted across the registry records on this site, refreshed daily.
pediatrics patients infected by multi-resistant bacterial, treated by new antibiotics
Treated with one or more of the following antibiotics:
In association with a documented infection performed by:
Normally sterile site
Sampling on material such as:Intubation probe, Orthopedic, Urological, Central Nervous System (CNS),....
Exclusion Criteria:
Relevance of prescribing "new antibiotics" according to patient status
Type of new antibiotics prescribed for pediatrics infections caused by multi-resistant bacteria according to the antibiogram of the isolated bacteria or in the absence of bacteriological documentation
Time frame: 1 year
Relevance of prescribing "new antibiotics"
how are used new antibiotics prescribed for pediatrics infections caused by multi-resistant bacteria
Time frame: 1 year
Describe Bacterial epidemiology of infections associated with prescription of new antibiotics
Characteristic of bacteria associated with prescription of new antibiotics
Time frame: 1 year
Identify Risks factors for multi-resistant bacteria
Type of conditions responsible of multi-resistant such as comorbidities, travel, previous hospitalization, previous antibiotherapy,
Time frame: 1 year
Describe Context of drug Prescription
How antibiotics medical prescriptions are controlled and validated
Time frame: 1 year
Department involved in medical prescribing
Number of department involved in medical prescriptions
Time frame: 1 year
Describe Associated Antibiotherapies type
Type of drug association prescribed
Time frame: 1 year
Describe Associated Antibiotherapies
Number of drug association prescribed
Time frame: 1 year
Describe patients outcome
Proportion of patients clinically and bacteriologically recovered
Time frame: 1 year
This study is completed, as verified in Mar 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Association Clinique Thérapeutique Infantile du val de Marne